Gas gangrene, or clostridial myonecrosis, is a rapidly progressive toxin-mediated soft-tissue infection caused mainly by Clostridium perfringens after trauma or surgery and less often by spontaneous Clostridium septicum infection in immunosuppressed or malignancy-associated settings.
Ask a research question about Gas Gangrene. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Gas Gangrene
creation_date: "2026-09-25T18:27:16Z"
category: Infectious Disease
disease_term:
preferred_term: gas gangrene
term:
id: MONDO:0005767
label: gas gangrene
description: >-
Gas gangrene, or clostridial myonecrosis, is a rapidly progressive
toxin-mediated soft-tissue infection caused mainly by Clostridium perfringens
after trauma or surgery and less often by spontaneous Clostridium septicum
infection in immunosuppressed or malignancy-associated settings.
parents:
- bacterial infectious disease with sepsis
- commensal bacterial infectious disease
- infection due to clostridium perfringens
- skin disease caused by bacterial infection
- vesiculobullous skin disease
synonyms:
- clostridial myonecrosis
infectious_agent:
- name: Clostridium perfringens
infectious_agent_term:
preferred_term: Clostridium perfringens
term:
id: NCBITaxon:1502
label: Clostridium perfringens
description: >-
An anaerobic spore-forming bacterium whose alpha-toxin and theta-toxin drive
the traumatic and postsurgical forms of clostridial myonecrosis.
evidence:
- reference: PMID:7746141
reference_title: "Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
quote_role: BACKGROUND
snippet: "The pathogenesis of clostridial myonecrosis, or gas gangrene, involves the growth of the anaerobic bacterium Clostridium perfringens in the infected tissues and the elaboration of numerous extracellular toxins and enzymes."
explanation: Establishes C. perfringens as the canonical clostridial species in experimentally modeled gas gangrene.
- reference: PMID:18034207
reference_title: "Neuromuscular and central nervous system manifestations of Clostridium perfringens infections."
supports: SUPPORT
evidence_source: OTHER
snippet: "Neuromuscular manifestations of C. perfringens infections are much more frequent than CNS manifestations and comprise myonecrosis (gas gangrene), rhabdomyolysis, myositis, fasciitis, affection of the neuromuscular transmission, or affection of the peripheral nerves."
explanation: Supports C. perfringens gas gangrene in human infection.
- name: Clostridium septicum
infectious_agent_term:
preferred_term: Clostridium septicum
term:
id: NCBITaxon:1504
label: Clostridium septicum
description: >-
An anaerobic clostridial species that causes rare spontaneous gas gangrene
associated with malignancy or immunosuppression.
evidence:
- reference: PMID:18555761
reference_title: "Successful management of spontaneous Clostridium septicum myonecrosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Spontaneous Clostridium septicum myonecrosis, or gas gangrene, is an extremely rare soft tissue infection associated with malignancy and immunosuppression."
explanation: Identifies C. septicum as a cause of spontaneous gas gangrene in a human clinical report.
transmission:
- name: Traumatic, postsurgical, or spontaneous clostridial seeding
description: >-
C. perfringens infection usually begins at a surgical wound, trauma site, or
gastrointestinal/urogenital focus, whereas spontaneous C. septicum myonecrosis
reflects non-traumatic seeding in hosts with malignancy or immunosuppression.
evidence:
- reference: PMID:18034207
reference_title: "Neuromuscular and central nervous system manifestations of Clostridium perfringens infections."
supports: SUPPORT
evidence_source: OTHER
snippet: "C. perfringens infections usually start from the site of a recent surgical wound or trauma, a gastrointestinal or urogenital problem, or occur in association with malignancy."
explanation: Supports surgical, traumatic, enteric, urogenital, and malignancy-associated portals for C. perfringens infection.
- reference: PMID:18555761
reference_title: "Successful management of spontaneous Clostridium septicum myonecrosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Spontaneous Clostridium septicum myonecrosis, or gas gangrene, is an extremely rare soft tissue infection associated with malignancy and immunosuppression."
explanation: Supports the atraumatic C. septicum branch of gas gangrene.
pathophysiology:
- name: Anaerobic clostridial toxin production in infected muscle
description: >-
In devitalized or otherwise permissive soft tissue, anaerobic C. perfringens
proliferates and elaborates extracellular toxins and enzymes that initiate
rapid skeletal-muscle necrosis.
evidence:
- reference: PMID:7746141
reference_title: "Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
quote_role: BACKGROUND
snippet: "The pathogenesis of clostridial myonecrosis, or gas gangrene, involves the growth of the anaerobic bacterium Clostridium perfringens in the infected tissues and the elaboration of numerous extracellular toxins and enzymes."
explanation: Links C. perfringens proliferation and exotoxin release to clostridial myonecrosis.
downstream:
- target: Alpha-toxin membrane injury
description: >-
Secreted alpha-toxin acts on host-cell membranes, initiating the
membrane-injury step of myonecrosis.
- name: Alpha-toxin membrane injury
description: >-
C. perfringens alpha-toxin is a phospholipase C/sphingomyelinase that binds
target-cell membranes through its C-terminal domain and triggers membrane
lipid turnover, endocytosis, and cell death.
evidence:
- reference: PMID:26633512
reference_title: "Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Alpha-toxin possesses phospholipase C and sphingomyelinase activities. The
toxin is composed of an N-terminal domain (1-250 aa, N-domain), which is
the catalytic site, and a C-terminal domain (251-370 aa, C-domain), which
is the membrane-binding site.
explanation: Supports alpha-toxin as a two-domain membrane-active enzyme in gas gangrene.
- reference: PMID:7746141
reference_title: "Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "The results showed that the plc mutants had demonstrably reduced virulence and therefore provided definitive genetic evidence for the essential role of alpha-toxin in gas gangrene or clostridial myonecrosis."
explanation: Provides allelic-exchange evidence that the alpha-toxin gene plc is required for full gas-gangrene virulence.
molecular_functions:
- preferred_term: phospholipase C activity
modifier: INCREASED
term:
id: GO:0004629
label: C-type glycerophospholipase activity
downstream:
- target: Alpha-toxin and theta-toxin vascular leukostasis
description: >-
Alpha-toxin membrane injury, together with theta-toxin, drives the
vascular leukostasis that follows.
- target: Systemic shock and hemolysis
description: >-
Absorbed alpha-toxin entering the circulation produces systemic shock and
erythrocyte lysis.
- name: Alpha-toxin and theta-toxin vascular leukostasis
description: >-
Alpha-toxin and perfringolysin O act together to produce vascular leukostasis;
toxin-damaged endothelium, platelet aggregation, leukocyte trapping, capillary
leak, and impaired oxygen delivery create a self-amplifying anaerobic and
necrotic muscle compartment.
evidence:
- reference: PMID:10456947
reference_title: "Use of genetically manipulated strains of Clostridium perfringens reveals that both alpha-toxin and theta-toxin are required for vascular leukostasis to occur in experimental gas gangrene."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Thus, both alpha-toxin and theta-toxin are necessary for the characteristic vascular leukostasis observed in clostridial myonecrosis."
explanation: Supports the need for both major toxins in the leukostasis branch of experimental gas gangrene.
- reference: PMID:11111933
reference_title: "The pathogenesis of clostridial myonecrosis."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Toxin-induced endothelial dysfunction and microvascular injury could also
cause loss of albumin, electrolytes, and water into the interstitial space
resulting in marked localized edema. These events, combined with
intravascular platelet aggregation and leukostasis, would increase venous
pressures and favor further loss of fluid and protein in the distal
capillary bed.
explanation: Connects endothelial injury, platelet aggregation, leukostasis, capillary leak, and edema in clostridial myonecrosis.
cell_types:
- preferred_term: vascular endothelial cell
term:
id: CL:0000115
label: endothelial cell
- preferred_term: skeletal muscle cell
term:
id: CL:0000188
label: cell of skeletal muscle
biological_processes:
- preferred_term: platelet aggregation
modifier: INCREASED
term:
id: GO:0070527
label: platelet aggregation
downstream:
- target: Edema
description: >-
Endothelial injury and capillary leak from leukostasis produce the marked
localized edema of gas gangrene.
- target: Myonecrosis
description: >-
Reduced arteriolar flow and anoxia from vascular leukostasis drive
progressive necrosis of large muscle groups.
- target: Pain
description: >-
Ischemic muscle injury produces the severe pain out of proportion to
external findings characteristic of clostridial myonecrosis.
- name: Systemic shock and hemolysis
description: >-
Absorbed clostridial toxins can enter the systemic circulation, causing shock
and multiorgan failure; in severe C. perfringens sepsis, alpha-toxin can lyse
erythrocyte membranes and produce massive intravascular hemolysis.
evidence:
- reference: PMID:11111933
reference_title: "The pathogenesis of clostridial myonecrosis."
supports: SUPPORT
evidence_source: OTHER
snippet: "When toxins reach arterial circulation, systemic shock and multiorgan failure rapidly ensue, and death is common."
explanation: Supports systemic shock as a consequence of circulating clostridial toxins.
- reference: PMID:27049736
reference_title: "Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
While C. perfringens sepsis is uncommon, it is often rapidly fatal because
the alpha toxin of this bacterium induces massive intravascular hemolysis
by disrupting red blood cell membranes.
explanation: Supports alpha-toxin-mediated intravascular hemolysis as a severe systemic C. perfringens branch.
cell_types:
- preferred_term: erythrocyte
term:
id: CL:0000232
label: erythrocyte
downstream:
- target: Shock
description: >-
Toxins reaching the arterial circulation precipitate systemic shock and
multiorgan failure.
- target: Hemolytic anemia
description: >-
Alpha-toxin lysis of erythrocyte membranes produces massive intravascular
hemolysis and hemolytic anemia.
phenotypes:
- name: Myonecrosis
phenotype_term:
preferred_term: Myonecrosis
term:
id: HP:0003713
label: Muscle fiber necrosis
description: >-
Coagulative necrosis of skeletal muscle is the defining lesion of clostridial
myonecrosis and the feature the disease is named for.
evidence:
- reference: PMID:26633512
reference_title: "Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Clostridium perfringens alpha-toxin is a key mediator of gas gangrene, which is a life-threatening infection that manifests as fever, pain, edema, myonecrosis, and gas production."
explanation: Names myonecrosis as a defining manifestation of gas gangrene.
- name: Fever
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
description: Fever accompanies the systemic toxemic response in clostridial myonecrosis.
evidence:
- reference: PMID:26633512
reference_title: "Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Clostridium perfringens alpha-toxin is a key mediator of gas gangrene, which is a life-threatening infection that manifests as fever, pain, edema, myonecrosis, and gas production."
explanation: Names fever among the recognized gas-gangrene manifestations.
- name: Pain
phenotype_term:
preferred_term: Pain
severity: SEVERE
term:
id: HP:0012531
label: Pain
description: >-
Severe pain, classically out of proportion to external findings, is part of
the acute local gas-gangrene presentation.
evidence:
- reference: PMID:26633512
reference_title: "Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin."
supports: SUPPORT
evidence_source: OTHER
quote_role: REVIEW_SYNTHESIS
snippet: "Clostridium perfringens alpha-toxin is a key mediator of gas gangrene, which is a life-threatening infection that manifests as fever, pain, edema, myonecrosis, and gas production."
explanation: Lists pain among the recognized gas-gangrene manifestations.
- name: Edema
phenotype_term:
preferred_term: Edema
term:
id: HP:0000969
label: Edema
description: Progressive local edema follows toxin-induced vascular leak in clostridial myonecrosis.
evidence:
- reference: PMID:11111933
reference_title: "The pathogenesis of clostridial myonecrosis."
supports: SUPPORT
evidence_source: OTHER
snippet: "Similarly, the direct cytotoxicity of PFO could disrupt endothelial integrity and contribute to progressive edema both locally and systemically."
explanation: Supports edema as a toxin-mediated manifestation of clostridial myonecrosis.
- name: Shock
phenotype_term:
preferred_term: Shock
term:
id: HP:0031273
label: Shock
description: Septic shock occurs when clostridial toxins and infection become systemic.
evidence:
- reference: PMID:11111933
reference_title: "The pathogenesis of clostridial myonecrosis."
supports: SUPPORT
evidence_source: OTHER
snippet: "When toxins reach arterial circulation, systemic shock and multiorgan failure rapidly ensue, and death is common."
explanation: Supports shock as a systemic consequence of toxin spread.
- name: Hemolytic anemia
phenotype_term:
preferred_term: Hemolytic anemia
term:
id: HP:0001878
label: Hemolytic anemia
description: Massive intravascular hemolysis can complicate severe C. perfringens sepsis.
evidence:
- reference: PMID:27049736
reference_title: "Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
While C. perfringens sepsis is uncommon, it is often rapidly fatal because
the alpha toxin of this bacterium induces massive intravascular hemolysis
by disrupting red blood cell membranes.
explanation: Supports hemolytic anemia as a rare but severe alpha-toxin-mediated complication.
treatments:
- name: Radical surgical debridement
treatment_term:
preferred_term: Surgical Procedure
term:
id: NCIT:C15329
label: Surgical Procedure
description: Gas gangrene requires urgent radical debridement of necrotic infected tissue.
evidence:
- reference: PMID:18034207
reference_title: "Neuromuscular and central nervous system manifestations of Clostridium perfringens infections."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Treatment of choice is surgical debridement of the infectious focus with
radical removal of all necrotic tissue, resection of the corresponding
lymphatics in addition to antibiotic therapy with penicillin G,
aminoglycosides, or clindamycin or hyperbaric oxygenation.
explanation: Supports surgical debridement as the central source-control treatment for C. perfringens gas gangrene.
- name: Antibiotic therapy
treatment_term:
preferred_term: Antibiotic Therapy
term:
id: NCIT:C15620
label: Antibiotic Therapy
therapeutic_agent:
- preferred_term: penicillin G
term:
id: CHEBI:18208
label: benzylpenicillin
- preferred_term: clindamycin
term:
id: CHEBI:3745
label: clindamycin
- preferred_term: metronidazole
term:
id: CHEBI:6909
label: metronidazole
description: >-
Antibiotic therapy complements source control, with toxin-suppressing agents
such as clindamycin suppressing alpha-toxin activity better than penicillin alone
in experimental C. perfringens gas gangrene.
evidence:
- reference: PMID:18034207
reference_title: "Neuromuscular and central nervous system manifestations of Clostridium perfringens infections."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Treatment of choice is surgical debridement of the infectious focus with
radical removal of all necrotic tissue, resection of the corresponding
lymphatics in addition to antibiotic therapy with penicillin G,
aminoglycosides, or clindamycin or hyperbaric oxygenation.
explanation: Supports antibiotics alongside radical surgery in gas-gangrene management.
- reference: PMID:2882731
reference_title: "Effect of antibiotics on toxin production and viability of Clostridium perfringens."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Because antibiotic efficacy did not correlate with bactericidal activity,
we measured alpha-toxin activity and found complete suppression of
alpha-toxin activity by tetracycline, metronidazole, rifampin, clindamycin,
and chloramphenicol at concentrations equal to the MIC.
explanation: Supports toxin suppression as the rationale for protein-synthesis-inhibiting antibiotics in experimental gas gangrene.
- name: Hyperbaric oxygen therapy
treatment_term:
preferred_term: hyperbaric oxygen therapy
term:
id: NCIT:C38065
label: Hyperbaric Oxygen Therapy
description: >-
Adjunctive hyperbaric oxygen is used alongside radical debridement and
antibiotics in clostridial myonecrosis.
evidence:
- reference: PMID:18034207
reference_title: "Neuromuscular and central nervous system manifestations of Clostridium perfringens infections."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Treatment of choice is surgical debridement of the infectious focus with
radical removal of all necrotic tissue, resection of the corresponding
lymphatics in addition to antibiotic therapy with penicillin G,
aminoglycosides, or clindamycin or hyperbaric oxygenation.
explanation: Names hyperbaric oxygenation among the treatment options for C. perfringens myonecrosis.
diagnosis:
- name: Blood culture with Gram stain
description: >-
Blood cultures growing large Gram-positive rods identify the clostridial
agent in systemic C. perfringens infection.
diagnosis_term:
preferred_term: blood culture
term:
id: NCIT:C25300
label: Microbial Culture Procedure
evidence:
- reference: PMID:27049736
reference_title: "Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
both of the 2 blood cultures obtained from the patient grew large
Gram-positive rods, which were definitively identified as C. perfringens.
explanation: Blood culture growing large Gram-positive rods established the clostridial diagnosis.
- name: Peripheral blood smear and hemolysis workup
description: >-
Fulminant C. perfringens sepsis is suggested by severe hemolytic anemia with
a very low MCV, a hemolyzed sample, and a negative Coombs test.
diagnosis_term:
preferred_term: peripheral blood smear microscopy
term:
id: NCIT:C16853
label: Microscopy
evidence:
- reference: PMID:27049736
reference_title: "Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
C. perfringens infection should be considered in a febrile patient who has
severe hemolytic anemia with a very low MCV, hemolyzed blood sample, and
negative Coombs test. The characteristic peripheral blood smear findings
may facilitate rapid diagnosis.
explanation: Peripheral-smear and hemolysis findings are given as the route to rapid diagnosis.
- name: Cross-sectional imaging for soft-tissue gas
description: >-
Computed tomography demonstrates gas within infected tissue or viscera,
though soft-tissue gas is not universal.
diagnosis_term:
preferred_term: computed tomography
term:
id: NCIT:C17204
label: Computed Tomography
evidence:
- reference: PMID:27049736
reference_title: "Clostridium Perfringens Infection in a Febrile Patient with Severe Hemolytic Anemia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Computed tomography of the abdomen showed an abscess with gas in the left
lobe of the liver and emphysematous cholecystitis.
explanation: CT identified gas-forming clostridial infection in this case.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Create: Gas Gangrene · 2026-09-25T18:49:39Z · View source
Created the MONDO:0005767 clostridial myonecrosis infectious disease entry from the OpenScientist report at research/Gas_Gangrene-deep-research-openscientist.md. The deep-research identity preflight returned SKIP, not FAIL, because MONDO records no human causal gene for this bacterial infection; manual preflight confirmed the report targeted gas gangrene / clostridial myonecrosis and the expected Clostridium perfringens and Clostridium septicum pathogen scope. Curated a compact human entry with the C. perfringens and C. septicum infectious agents, traumatic/postsurgical/spontaneous clostridial seeding, alpha-toxin and theta-toxin pathophysiology branches, systemic shock/hemolysis, four phenotypes, and surgical plus antibiotic treatment records. Used eight quotable cached PMID records and avoided report leads that validation flagged as unsupported, off-topic, or mislabelled, including veterinary blackleg references and the bad UBERON fascia and CHEBI ceramide CURIEs. Validation during curation: just validate-terms, just count-verified-snippets, just validate, and just validate-disorders all passed for the new disorder file.
The single most important molecular determinant of C. perfringens gas gangrene is alpha-toxin (CPA/PLC), a phospholipase C / sphingomyelinase. Its N-terminal domain (residues 1–250) is catalytic and its C-terminal domain (251–370) is the membrane-binding site; immunization with the C-domain prevents gas gangrene in mice while N-domain immunization does not. Mechanistically, the toxin binds lipid rafts via a GM1a/TrkA complex, generates diacylglycerol, and activates endogenous PLCγ-1 through TrkA, triggering endocytosis and cell death. Clostridium perfringens alpha-toxin "is a key mediator of gas gangrene… manifest[ing] as fever, pain, edema, myonecrosis, and gas production. Alpha-toxin possesses phospholipase C and sphingomyelinase activities" (PMID: 26633512). Downstream, the toxin "specifically induces endothelial cell death by promoting ceramide-mediated apoptosis" (PMID: 32828915) and impairs muscle regeneration by dose-dependently decreasing MyoD and myogenin in C2C12 myoblasts (PMID: 32860931). (in vitro / model organism)
Both PLC (alpha-toxin) and perfringolysin O (theta-toxin) act on venous capillary endothelium: PLC strongly induces ELAM-1 (E-selectin), ICAM-1, and IL-8 and converts endothelial cells to a fibroblastoid morphology; PFO induces early ICAM-1 and causes direct endothelial death. "The toxin-induced expression of proadhesive and activational proteins and direct cytopathic effects may contribute to the leukostasis, vascular compromise, and capillary leak characteristic of C. perfringens gas gangrene" (PMID: 8557365). The disease is "initiated by direct toxin effects upon venous capillary endothelial cell function, leading to expression of pro-inflammatory mediators and adhesion molecules, and initiation of platelet aggregation" (PMID: 11111933). This produces leukocyte hyperadhesion with impaired chemotaxis, leukostasis, capillary leak, regional ischemia, and progressive edema. (in vitro / review)
"Spontaneous Clostridium septicum myonecrosis, or gas gangrene, is an extremely rare soft tissue infection associated with malignancy and immunosuppression. Even with appropriate treatment the mortality rate approaches 100%" (PMID: 18555761). "Atraumatic infections due to Clostridium septicum are known to be associated with immunosuppression or even malignancy" (PMID: 16021394). Multiple case reports document C. septicum bacteremia/myonecrosis revealing occult colon or rectal cancer (PMID: 10901913; PMID: 18019648), mandating GI malignancy workup. By contrast, traumatic/post-surgical disease is predominantly C. perfringens type A (PMID: 18034207). (human clinical)
"Treatment of choice is surgical debridement of the infectious focus with radical removal of all necrotic tissue, resection of the corresponding lymphatics in addition to antibiotic therapy with penicillin G, aminoglycosides, or clindamycin or hyperbaric oxygenation" (PMID: 18034207). In a Duke HBO series of 49 patients: "Survival in patients with involvement confined to the extremities was 92.3 percent… combined involvement of extremity and trunk was 53.3 percent, and with primary trunk involvement half… survived. Survival for the entire series was 73.5 percent" (PMID: 162815). Nonclostridial gas gangrene carries ~43% mortality, worsened by delay (PMID: 11782626). (human clinical)
"The toxin is a 370-residue, zinc metalloenzyme that has phospholipase C activity, and can bind to membranes in the presence of calcium. The crystal structure of the enzyme reveals a two-domain protein" (PMID: 9699639). The N-terminal catalytic domain resembles Bacillus cereus PC-PLC; "The C-terminal domain shows a strong structural analogy to eukaryotic calcium-binding C2 domains. We believe this is the first example of such a domain in prokaryotes" (PMID: 9699639). C2 domains bind phospholipid/calcium in intracellular second-messenger proteins — pathways the toxin perturbs. (structural)
In a Medicare NSTI cohort of adults ≥65 (n=1427), 97% required emergency surgery and "The overall mortality was 5.3%. Several underlying comorbidities were associated with higher rates of mortality including cancer (OR: 3.50, P = 0.0009), liver disease (OR: 2.97, P = 0.03), and kidney disease (OR: 2.15, P = 0.01)" (PMID: 32818779). A validated NSQIP calculator (n=1392) reported 13% 30-day mortality with independent predictors including "age older than 60 years (odds ratio [OR] = 2.5; 95% CI 1.7–3.6)" plus dialysis (1.9), ASA ≥4 (3.6), septic shock (2.4), and platelets <50K (3.5) (PMID: 23628224). Pediatric NSTI is rare (355 US cases, 2016–2020) (PMID: 38518580). (human clinical)
"Blackleg is an infectious disease that mainly affects cattle and rarely affects other ruminants. It is characterized by hemorrhagic blackleg myositis" (PMID: 40989646) and "is a soil-borne disease primarily affecting cattle and is caused by Clostridium chauvoei" (PMID: 42743700). It is endemic in regions such as Ethiopia and Kazakhstan with strong seasonal (post-rainy/November) peaks (PMID: 41133194), with novel presentations including intestinal necrosis in calves (PMID: 42545146). Unlike traumatic human disease, blackleg is typically endogenous — latent muscle spores activated by hypoxia. Controlled by multivalent clostridial vaccines. (veterinary)
"C. perfringens sepsis is uncommon, [but] it is often rapidly fatal because the alpha toxin of this bacterium induces massive intravascular hemolysis by disrupting red blood cell membranes" (PMID: 27049736); characteristic labs are severe hemolytic anemia with very low MCV, spherocytes, hemolyzed sample, and negative Coombs. Fulminant C. perfringens bacteremia is "severe and fatal in fifty per cent of cases" (PMID: 37110247). In a 13-year series, fatal intravascular hemolysis occurred in ~3.0% (1/33) of C. perfringens infections (PMID: 25755747). "Serum PLC activity… showed a nearly fivefold increase (6.0 to 27.3 U/l), which is consistent with the hypothesized dominant role of this enzyme" (PMID: 8373904); death can occur within 4–8 hours of admission (PMID: 1776111). (human clinical)
"Clindamycin is more efficacious than penicillin in experimental gas gangrene caused by Clostridium perfringens in animals" (PMID: 7548539). Efficacy tracks toxin suppression, not bactericidal activity: "complete suppression of alpha-toxin activity by tetracycline, metronidazole, rifampin, clindamycin, and chloramphenicol at concentrations equal to the MIC. In contrast, alpha-toxin activity persisted at concentrations of penicillin equal to and above the MIC" (PMID: 2882731). This underpins the guideline-recommended penicillin + clindamycin combination. (model organism)
Allelic-exchange inactivation of the chromosomal plc gene showed "the plc mutants had demonstrably reduced virulence and therefore provided definitive genetic evidence for the essential role of alpha-toxin in gas gangrene" (PMID: 7746141). Alpha-toxin and PFO act synergistically: "the isogenic strain that was reconstituted for both toxins produced a pathology that was clearly more severe than when alpha-toxin alone was reconstituted" (PMID: 11705975). Both are required for leukostasis: "significantly reduced leukocyte aggregation when alpha-toxin was absent and complete abrogation… when theta-toxin was absent. Thus, both alpha-toxin and theta-toxin are necessary for the characteristic vascular leukostasis" (PMID: 10456947). By contrast, alpha-clostripain (ccp) is dispensable (PMID: 21829506). (model organism)
"Tissue gas is not a universal finding in necrotizing soft tissue infections. This misconception… contributes to diagnostic errors. Incision and drainage is an inappropriate surgical strategy… excisional debridement is needed" (PMID: 10621873). "The two commonest pitfalls in management are failure of early diagnosis and inadequate surgical debridement" (same source). For severe SSTIs, "intensive care, source control, and broad-spectrum antimicrobials are required for the initial phase of illness," with growing use of rapid diagnostics and ongoing IVIG debate (PMID: 29278528). (review)
TRAUMA/SURGERY (C. perfringens) GI LESION/MALIGNANCY (C. septicum)
│ │
└───────────────┬────────────────────────────┘
▼
Anaerobic niche → clostridial growth
▼
ALPHA-TOXIN (plc, PLC) + THETA-TOXIN (pfoA, PFO)
│ │ │
▼ ▼ ▼
membrane hydrolysis endothelial injury RBC lysis (systemic)
→ DAG/ceramide + E-sel/ICAM-1/IL-8 │
→ endothelial + │ ▼
myocyte apoptosis; ▼ MASSIVE INTRAVASCULAR
↓MyoD/myogenin leukocyte hyperadhesion HEMOLYSIS → DIC,
│ (BOTH toxins required) MOF, death (hrs)
│ ▼
│ VASCULAR LEUKOSTASIS → capillary leak,
│ ischemia, spreading EDEMA
└──────────────┬───────────────┘
▼
SPREADING MYONECROSIS + TISSUE GAS → SEPTIC SHOCK
▼
── Interrupted only by: EMERGENCY EXCISIONAL DEBRIDEMENT
+ PENICILLIN/CLINDAMYCIN (toxin suppression) + HBO ──
The unifying theme is exotoxin-driven vascular and myofiber destruction with a self-amplifying ischemic loop: toxins kill endothelium and jam neutrophils in capillaries, which starves tissue of oxygen and immune defense, which further favors clostridial growth. Because the damage is enzymatic and toxin-mediated rather than dependent on bacterial burden alone, therapy must both remove the substrate (surgery) and silence the toxin (protein-synthesis-inhibiting antibiotics) — the direct rationale for the penicillin + clindamycin combination.
Overview. A rapidly progressive, life-threatening necrotizing infection of skeletal muscle caused by toxin-producing Clostridium species, most often C. perfringens type A, characterized by "fever, pain, edema, myonecrosis, and gas production" (PMID: 26633512). It is one member of the broader necrotizing soft tissue infections (NSTIs) (PMID: 32818779; PMID: 10621873).
Key identifiers. MONDO:0005767 · ICD-10 A48.0 · ICD-11 (gas gangrene) · MeSH D005738 · SNOMED CT 372070002. OMIM/Orphanet: not applicable — acquired infection, not a Mendelian disorder.
Synonyms. Clostridial myonecrosis; clostridial gas gangrene; myonecrosis; emphysematous gangrene. In animals: blackleg (C. chauvoei), malignant edema (C. septicum/C. perfringens).
Information source. Disease-level aggregated resources (reviews, case series, mouse pathogenesis studies); population burden from administrative/registry datasets coded at the NSTI level (PMID: 32818779; PMID: 23628224; PMID: 38518580).
Primary cause — infectious. Anaerobic, spore-forming Clostridium bacilli via two routes: (1) traumatic/post-surgical — predominantly C. perfringens type A (NCBITaxon:1502) in devitalized muscle (PMID: 18034207); (2) spontaneous/hematogenous — predominantly C. septicum (NCBITaxon:1504), associated with occult GI malignancy, neutropenia, immunosuppression (PMID: 18555761; PMID: 16021394). Other agents: C. novyi, C. histolyticum, C. sordellii.
Risk factors (host/environmental). Penetrating/crush trauma, open fractures, contaminated wounds, GI/biliary surgery, septic abortion; diabetes mellitus (PMID: 11782626); malignancy (OR 3.50), liver disease (OR 2.97), renal disease (OR 2.15) (PMID: 32818779); chemotherapy/neutropenia/cirrhosis (PMID: 25755747); age >60, male sex (~59%) (PMID: 23628224).
Genetic risk factors (human host): none established — not applicable. Protective factors: prompt wound debridement, tissue oxygenation, veterinary toxoid vaccination; no human genetic protective variants. Gene–environment interaction: operates as pathogen-genotype × host-microenvironment (toxin genes expressed under anaerobic necrotic conditions).
| Phenotype | Type | Characteristics | HPO |
|---|---|---|---|
| Severe pain out of proportion | Symptom | Early, near-universal | HP:0012531 |
| Myonecrosis | Pathological sign | Severe, progressive; defining | HP:0003202 (proxy) |
| Soft-tissue gas/crepitus | Sign | Variable — not universal (PMID: 10621873) | HP:0025439 |
| Tense edema | Sign | Severe, progressive (PMID: 11111933) | HP:0000969 |
| Skin discoloration/hemorrhagic bullae | Physical | Progressive | HP:0011121 |
| Fever | Symptom | Common | HP:0001945 |
| Septic shock/hypotension | Sign | Late/systemic | HP:0031273 |
| Hemolytic anemia | Lab | Rare (~3%), often fatal (PMID: 27049736) | HP:0001878 |
| DIC | Lab/clinical | Severe complication (PMID: 9163265) | HP:0005521 |
| Rhabdomyolysis/↑CK/acute renal failure | Lab | Severe (PMID: 9163265) | HP:0003236; HP:0000083 |
Onset: acute (hours–days); adult predominance. Progression: fulminant. Quality of life: survivors often undergo amputation/extensive debridement with lasting disability; disease-specific EQ-5D/SF-36 data not available.
Human causal genes: none — not applicable. No human causal genes, pathogenic variants, modifier genes, epigenetic marks, or chromosomal abnormalities.
Pathogen virulence genes (operative molecular determinants): - plc → alpha-toxin (CPA), 370-aa zinc-metalloenzyme PLC/sphingomyelinase, UniProt P0C216; essential (PMID: 7746141). - pfoA → perfringolysin O (theta-toxin), cholesterol-dependent cytolysin, UniProt P0C2E9; synergistic, required for leukostasis (PMID: 11705975; PMID: 10456947). - ccp → alpha-clostripain; dispensable (PMID: 21829506). - cpe/*ccpA → enterotoxin/regulator; CcpA does not* regulate PLC (PMID: 15292123).
Toxinotyping: C. perfringens type A (cpa/plc+) is the principal agent; cpa/type A confirmed in fatal hemolysis (PMID: 25755747).
Clostridial spores reside in soil, dust, and mammalian GI tracts; wound contamination with soil/foreign bodies is the classic exposure. Blackleg is explicitly soil-borne with seasonal peaks (PMID: 42743700). Lifestyle: injection drug use, smoking/diabetes (impaired perfusion). Infectious agents (NCBI Taxonomy): C. perfringens (1502), C. septicum (1504), C. novyi (1522), C. histolyticum (1498), C. sordellii (1505), C. chauvoei (1494). Nonclostridial gas gangrene (mixed aerobic/anaerobic) has ~43% mortality (PMID: 11782626).
See the Mechanistic Model section above for the full ordered causal chain and diagram. Key category detail: - Molecular pathways: phospholipid/sphingolipid hydrolysis → DAG/ceramide; TrkA/PLCγ-1 activation; ceramide→apoptosis (GO:0004629 phospholipase C activity; GO:0006672 ceramide metabolic process) (PMID: 26633512; PMID: 32828915). - Cellular processes: apoptosis (GO:0006915), inflammation, blocked myogenesis (GO:0042692), platelet aggregation (GO:0070527) (PMID: 32860931). - Protein dysfunction: bacterial gain-of-toxic-function; two-domain zinc metalloenzyme (PMID: 9699639). - Immune involvement: paradoxical leukostasis with failure of neutrophil tissue entry; IL-8 induction (PMID: 8557365). - Tissue damage: ischemia, direct cytolysis, coagulative necrosis, hemolysis. - Omics: no large-scale human transcriptomic/proteomic/metabolomic disease atlases identified — data are targeted in vitro/mouse. Omics largely not available. - Cell types (CL): endothelial cell (CL:0000115), skeletal muscle cell (CL:0000188), myoblast (CL:0000056), erythrocyte (CL:0000232), neutrophil (CL:0000775), platelet (CL:0000233).
Primary: skeletal muscle (UBERON:0001134) and its microvasculature; secondarily subcutaneous tissue/fascia (UBERON:0007844). Body systems: musculoskeletal (primary), cardiovascular/microvascular (UBERON:0001982 capillary; UBERON:0001986 endothelium), hematologic (RBC hemolysis), with systemic sepsis affecting kidneys, lungs, coagulation (PMID: 9163265). Subcellular (GO CC): plasma membrane (GO:0005886), membrane raft (GO:0045121), extracellular region (GO:0005576). Localization: typically unilateral/focal at the wound, spreading proximally; spontaneous C. septicum can be multifocal/distant.
Onset: acute, incubation <24 h to a few days (traumatic); adult/geriatric. Progression: fulminant, monophasic (early local pain/edema → intermediate discoloration/bullae/crepitus/toxicity → advanced myonecrosis/shock/hemolysis). Not relapsing/chronic. Remission is treatment-induced via surgical source control (PMID: 18555761). Critical period: the first hours — time-to-debridement is the dominant modifiable survival determinant (PMID: 11782626; PMID: 10621873).
Epidemiology: rare; invasive C. perfringens ~0.017% of samples in one series (PMID: 25755747); pediatric NSTI very rare (355 US cases 2016–2020) (PMID: 38518580). Inheritance: not applicable (all genetic-etiology sub-items — penetrance, expressivity, anticipation, mosaicism, founder effect, consanguinity, carrier frequency — N/A). Demographics: male predominance (~59%) (PMID: 32818779); older/comorbid populations over-represented. Geographic: worldwide, historically battlefield-associated; veterinary blackleg endemic to specific soils (PMID: 42743700; PMID: 41133194).
Clinical diagnosis paramount (PMID: 10621873). Labs: leukocytosis, markedly elevated CK, lactic acidosis; in hemolysis — severe anemia, low MCV, spherocytes, negative Coombs (PMID: 27049736); DIC panel. Microbiology: Gram stain (large Gram-positive bacilli, few leukocytes), anaerobic culture, PCR toxin-gene typing on tissue (PMID: 25755747); intragranulocytic bacilli on blood smear in sepsis (PMID: 1776111). Imaging: CT/MRI show soft-tissue gas dissecting fascial planes — but gas not universal (PMID: 42348105; PMID: 10621873). Definitive: surgical exploration (necrotic, non-contractile muscle). Differential: necrotizing fasciitis, crepitant cellulitis, pyomyositis. Spontaneous C. septicum → occult GI malignancy workup (PMID: 16021394). Genetic/omics/screening: not applicable.
Mortality high and extent-dependent: 73.5% overall survival, 92.3% extremity-only, ~53% extremity+trunk, 50% trunk (HBO series) (PMID: 162815); 5.3% in-hospital (older adults) to 13% 30-day (NSQIP) (PMID: 32818779; PMID: 23628224); nonclostridial ~43% (PMID: 11782626); spontaneous C. septicum ~100% (PMID: 18555761); bacteremia with hemolysis ~50% (PMID: 37110247). Prognostic factors: anatomic extent, time-to-debridement, age >60, septic shock, ASA ≥4, dialysis, thrombocytopenia (PMID: 23628224), comorbidity (PMID: 32818779). Morbidity: amputation, tissue loss, long-term disability. Recovery possible with early radical surgery.
Triad (urgent, simultaneous): (1) Surgical — radical excisional debridement, fasciotomy, amputation as needed, repeat debridement (PMID: 18034207; PMID: 10621873); NCIT: Surgical Debridement (C15329), Amputation (C15275). (2) Antibiotics — penicillin G + clindamycin (clindamycin suppresses toxin synthesis) (PMID: 2882731; PMID: 7548539); alternatives metronidazole/tetracycline/aminoglycosides; NCIT: Penicillin G (C716), Clindamycin (C376), Metronidazole (C639). (3) HBO, adjunctive (PMID: 162815); NCIT: Hyperbaric Oxygen Therapy (C15683) — secondary to surgery (PMID: 10621873). Supportive ICU care, resuscitation, shock/DIC/renal management (PMID: 29278528). Experimental: IVIG (debated); anti-alpha-toxin C-domain immunotherapy protective in mice (PMID: 26633512). Pharmacogenomics: not applicable.
Primary: meticulous wound care, early debridement, avoiding tight closure of contaminated wounds (PMID: 10621873; PMID: 162815). Secondary: early recognition + rapid surgery; occult GI malignancy workup in C. septicum (PMID: 16021394). Tertiary: aggressive source control + ICU support. Immunization (humans): no licensed vaccine (C-domain alpha-toxoid protective experimentally only, PMID: 26633512). Veterinary: multivalent clostridial toxoids prevent blackleg/malignant edema (PMID: 40989646). Genetic counseling/carrier screening: not applicable.
Hosts: cattle Bos taurus (NCBITaxon:9913), sheep Ovis aries (9940), other ruminants. Blackleg (C. chauvoei, NCBITaxon:1494) — soil-borne, highly lethal hemorrhagic emphysematous myositis, typically endogenous (PMID: 40989646; PMID: 42743700); novel intestinal-necrosis presentation (PMID: 42545146); atypical prolonged courses (PMID: 42651908). Malignant edema (C. septicum/C. perfringens/C. novyi) from wound contamination. Veterinary importance: major cause of sudden death/economic loss, managed by vaccination (PMID: 41133194). Comparative pathology: shared core mechanism, differing route (endogenous latency vs traumatic contamination). Alpha-toxin also implicated in animal sudden-death syndrome (PMID: 9699639). Zoonotic potential: minimal — environmental/endogenous acquisition, not animal-to-human transmission.
Primary — mouse myonecrosis model (i.m./footpad C. perfringens inoculation): workhorse for pathogenesis, high fidelity to human histopathology (PMID: 7746141; PMID: 11705975; PMID: 10456947; PMID: 2882731). Genetic models (bacterial): isogenic allelic-exchange/TargeTron knockouts of plc, pfoA, ccp with complementation (PMID: 7746141; PMID: 21829506). In vitro: C2C12 myoblasts (PMID: 32860931), HUVEC (PMID: 8557365), CD31+ endothelial cells (PMID: 32828915), erythrocyte hemolysis (PMID: 24349173). Structural/computational: alpha-toxin crystal structure (PMID: 9699639); in silico N–C domain docking (PMID: 24349173). Limitations: mouse models emphasize local toxin-driven process; less capture of human comorbidity context and the spontaneous C. septicum/malignancy axis. No host-genetic disease lines (host is not predisposed). Resources: C. perfringens strain 13; ATCC 13124.
| PMID | Contribution | Evidence type |
|---|---|---|
| 7746141 | Genetic proof alpha-toxin (plc) essential | Model organism |
| 11705975 | Alpha-toxin × PFO synergy | Model organism |
| 10456947 | Both toxins required for leukostasis | Model organism |
| 26633512 | Alpha-toxin mechanism; clinical features; C-domain vaccine | In vitro/review |
| 9699639 | Crystal structure; novel prokaryotic C2 domain | Structural |
| 32828915 | Ceramide-mediated endothelial apoptosis | In vitro |
| 32860931 | Impaired myogenesis (↓MyoD/myogenin) | In vitro |
| 8557365 | Adhesion molecule/IL-8 upregulation | In vitro |
| 11111933 | Pathogenesis causal chain | Review |
| 18555761 | Spontaneous C. septicum, ~100% mortality | Human |
| 16021394 | Atraumatic C. septicum ↔ malignancy | Human |
| 27049736 | Alpha-toxin → massive hemolysis | Human |
| 8373904 | Rising PLC drives hemolysis | Human |
| 162815 | HBO survival by anatomic extent | Human |
| 18034207 | Standard treatment triad | Review |
| 2882731 | Clindamycin > penicillin (toxin suppression) | Model organism |
| 10621873 | Gas not universal; excisional debridement | Review |
| 32818779 | NSTI comorbidity mortality ORs | Human |
| 23628224 | Validated NSTI mortality predictors | Human |
| 40989646 / 42743700 | Blackleg (C. chauvoei) | Veterinary |
Human clinical: PMID 18034207, 18555761, 16021394, 10901913, 18019648, 11782626, 9163265, 162815, 27049736, 25755747, 8373904, 1776111, 37110247, 32818779, 23628224, 38518580, 10621873, 29278528, 42348105. Model organism (mouse): PMID 7746141, 11705975, 10456947, 2882731, 7548539, 21829506. In vitro: PMID 26633512, 32828915, 32860931, 8557365, 24349173. Structural/computational: PMID 9699639, 24349173. Veterinary: PMID 40989646, 42743700, 41133194, 42545146, 42651908.
Report compiled from 11 confirmed findings and 46 reviewed papers over 5 investigation iterations.
Checked with linkml-reference-validator 0.3.0rc1.
| Outcome | Count |
|---|---|
| References checked | 38 |
| Resolved | 38 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 23 |
| Quoted claims found in source | 16 |
| Quoted claims not found in source | 7 |
| References weighed for topical relevance | 38 |
| On topic | 23 |
| Off topic | 2 |
Searched the abstract, any retrieved full text, and the title. A quote drawn from a part of the paper that was not retrieved will appear here too, so check before treating one as invented:
Every one of these was searched against an abstract alone, with no full text retrieved - marked abstract only below. Where full text can be fetched, re-running with it will settle them; where the source publishes only a summary to PubMed, as GeneReviews chapters do, it will not, and the quote has to be checked by hand against the chapter itself.
PMID:26633512 (abstract only): "is a key mediator of gas gangrene… manifest[ing] as fever, pain, edema, myonecrosis, and gas production. Alpha-toxin possesses phospholipase C and sphingomyelinase activities"PMID:32828915 (abstract only): "specifically induces endothelial cell death by promoting ceramide-mediated apoptosis"PMID:8557365 (abstract only): "The toxin-induced expression of proadhesive and activational proteins and direct cytopathic effects may contribute to the leukostasis, vascular compromise, and capillary leak characteristic of C. perfringens gas gangrene"PMID:162815 (abstract only): "Survival in patients with involvement confined to the extremities was 92.3 percent… combined involvement of extremity and trunk was 53.3 percent, and with primary trunk involvement half… survived. Survival for the entire series was 73.5 percent"PMID:8373904 (abstract only): "Serum PLC activity… showed a nearly fivefold increase (6.0 to 27.3 U/l), which is consistent with the hypothesized dominant role of this enzyme"PMID:10456947 (abstract only): "significantly reduced leukocyte aggregation when alpha-toxin was absent and complete abrogation… when theta-toxin was absent. Thus, both alpha-toxin and theta-toxin are necessary for the characteristic vascular leukostasis"PMID:10621873 (abstract only): "Tissue gas is not a universal finding in necrotizing soft tissue infections. This misconception… contributes to diagnostic errors. Incision and drainage is an inappropriate surgical strategy… excisional debridement is needed"These identifiers resolve, so they are not fabrications, but the records they resolve to share almost none of this report's vocabulary. That is a clue and not a verdict - a paper can be relevant in ways its title and abstract do not spell out - so read them before deciding:
PMID:42743700 (10 mentions) - Spatiotemporal patterns and ecological niche modeling of Blackleg in cattle in the Western Amhara region, Ethiopia, 2018-2023.PMID:41133194 (7 mentions) - Blackleg in cattle in Kazakhstan: regional epizootology, seasonal patterns, and molecular identification of the pathogen.Weighed against this report's own most characteristic terms: gas, human, septicum, disease, gangrene, perfringen, alpha-toxin, plc, tissue, hemolysis, toxin, model, clinical, myonecrosis, muscle, spontaneous, debridement, genetic, malignancy, edema.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 39 |
| Resolved | 39 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 0 |
| Terms whose name was checked | 34 |
| Terms named correctly | 17 |
| Terms named as a different term | 11 |
| Terms whose name is worth a second look | 6 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
HP:0012531 (1 mention) - the report calls it "Early, near-universal"; HP calls it PainHP:0003202 (1 mention) - the report calls it "proxy"; HP calls it Skeletal muscle atrophyHP:0025439 (1 mention) - the report calls it "Variable — not universal (PMID: 10621873)"; HP calls it PharyngitisHP:0000969 (1 mention) - the report calls it "Severe, progressive (PMID: 11111933)"; HP calls it EdemaHP:0011121 (1 mention) - the report calls it "Progressive"; HP calls it Abnormal skin morphologyHP:0001945 (1 mention) - the report calls it "Common"; HP calls it FeverHP:0031273 (1 mention) - the report calls it "Late/systemic"; HP calls it ShockHP:0001878 (1 mention) - the report calls it "Rare (~3%), often fatal (PMID: 27049736)"; HP calls it Hemolytic anemiaHP:0005521 (1 mention) - the report calls it "Severe complication (PMID: 9163265)"; HP calls it Disseminated intravascular coagulationUBERON:0007844 (2 mentions) - the report calls it "fascia"; UBERON calls it cartilage elementCHEBI:16040 (1 mention) - the report calls it "ceramide"; CHEBI calls it cytosineThe report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
NCBITaxon:1504 (1 mention) - the report calls it "C. septicum"; NCBITaxon calls it Clostridium septicumGO:0004629 (2 mentions) - the report calls it "phospholipase C activity"; GO calls it C-type glycerophospholipase activity, and lists "phospholipase C activity" among its other namesGO:0006915 (2 mentions) - the report calls it "Cellular processes: apoptosis", "apoptosis"; GO calls it apoptotic process**, and lists "activation of apoptosis" among its other namesCL:0000188 (2 mentions) - the report calls it "skeletal muscle cell"; CL calls it cell of skeletal muscle, and lists "skeletal muscle cell" among its other namesUBERON:0001134 (2 mentions) - the report calls it "skeletal muscle"; UBERON calls it skeletal muscle tissue, and lists "skeletal muscle" among its other namesCHEBI:17636 (1 mention) - the report calls it "sphingomyelin"; CHEBI calls it sphingomyelin d18:1, and lists "Sphingomyelin" among its other namesThe report gives these identifiers more than one name of its own:
GO:0006915 - called "Cellular processes:** apoptosis", "apoptosis"